Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Association of Medical Stimulants With Mortality in the US From 2010 to 2017
The role of nonopioids in the drug overdose epidemic in the US is frequently overshadowed. From 2015 to 2016, mortality rates involving cocaine and psychostimulants were smaller than opioids, but were rising faster than opioids.1 We examined individual substances listed on death certificates to better understand stimulant-associated mortality and assess rates over time.
The role of nonopioids in the drug overdose epidemic in the US is frequently overshadowed. From 2015 to 2016, mortality rates involving cocaine and psychostimulants were smaller than opioids, but were rising faster than opioids.1 We examined individual substances listed on death certificates to better understand stimulant-associated mortality and assess rates over time.
Association between county level cannabis dispensary counts and opioid related mortality rates in the United States
Higher medical and recreational storefront dispensary counts are associated with reduced opioid related death rates, particularly deaths associated with synthetic opioids such as fentanyl. This study highlights the importance of considering the complex supply side of related drug markets and how this shapes opioid use and misuse.
Higher medical and recreational storefront dispensary counts are associated with reduced opioid related death rates, particularly deaths associated with synthetic opioids such as fentanyl. This study highlights the importance of considering the complex supply side of related drug markets and how this shapes opioid use and misuse.
2019-2020 DRUG TREND REPORT
This report covers drug trends, explores the drivers behind drug related deaths and gives insight into the impact of the global pandemic and lockdown restrictions.
This report covers drug trends, explores the drivers behind drug related deaths and gives insight into the impact of the global pandemic and lockdown restrictions.
Methamphetamine overdose deaths rise sharply in USA
Methamphetamine overdose deaths surged in an eight-year period in the United States, according to a study published today. The analysis revealed rapid rises across all racial and ethnic groups, but American Indians and Alaska Natives had the highest death rates overall. The research was conducted at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
Methamphetamine overdose deaths surged in an eight-year period in the United States, according to a study published today. The analysis revealed rapid rises across all racial and ethnic groups, but American Indians and Alaska Natives had the highest death rates overall. The research was conducted at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
Shooting Up: infections among people who inject drugs in the UK, 2019
Drug use in the United Kingdom (UK) is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. Through this report, we explore infections, associated risks and behaviours among PWID in the UK to the end of 2019, as well as presenting preliminary data on the impact of COVID-19 on PWID and services in 2020.
Drug use in the United Kingdom (UK) is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. Through this report, we explore infections, associated risks and behaviours among PWID in the UK to the end of 2019, as well as presenting preliminary data on the impact of COVID-19 on PWID and services in 2020.
COVID-19 and people who use drugs; seizing opportunity in times of chaos
COVID-19 holds the world in a tight grip. In these unprecedented times, health and health-system capacities have been on the top of the global agenda for several months. Many countries have rolled out far-reaching prevention measure such as physical distancing and ‘lock-downs’ to prevent (further) overwhelming of health system capacities. In many contexts, people who use drugs are a vulnerable population, prone to poor access to health services compounded by criminalization, and stigmatisation in health-care settings.
COVID-19 holds the world in a tight grip. In these unprecedented times, health and health-system capacities have been on the top of the global agenda for several months. Many countries have rolled out far-reaching prevention measure such as physical distancing and ‘lock-downs’ to prevent (further) overwhelming of health system capacities. In many contexts, people who use drugs are a vulnerable population, prone to poor access to health services compounded by criminalization, and stigmatisation in health-care settings.
Covid-19 and the impact on harm reduction in Europe
Launch of the special harm reduction journal edition
Launch of the special harm reduction journal edition
The Global State of Harm Reduction 2020
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world. Now in its the seventh edition, the Global State of Harm Reduction 2020 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis.
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world. Now in its the seventh edition, the Global State of Harm Reduction 2020 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis.
